LANGHORNE, Pa. Health and personal care giant Johnson & Johnson was urged to take down an online video ad for Motrin brand ibuprophen geared towards mothers who suffer pain from carrying babies during the day after some Internet users responded that the ad was insensitive, reports said.

The video interstitial featured a barrage of moving text and line art images which showed back, neck and shoulder pain related to carrying babies in slings and packs. Some viewers took issue with the use of language that suggested carrying a baby all day was “in fashion,” as well as other statements related to motherhood and pain.

CHICAGO A trial published last week in the Journal of the American Medical Association determined that low-dose aspirin as a primary prevention tool against heart disease was ineffective in patients with Type 2 diabetes.

The study followed 2,539 Japanese patients diagnosed with Type 2 diabetes from December 2002 through April 2008 who had no prior incidence of heart disease. A total of 68 heart-disease events occurred in the group taking low-dose aspirin, vs. 86 events among those not taking any aspirin therapy.

Accordingly, the authors of the study concluded that in patients with Type 2 diabetes, low-dose aspirin as a primary prevention did not reduce the risk of cardiovascular events.

The Center for Drug Evaluation and Research, in a consumer education post on its web site, states that low-dose aspirin has been shown to be helpful when used daily to lower the risk of heart attack, clot-related strokes and other blood flow problems, so long as consumers consult a healthcare professional to talk about the use of low-dose aspirin on a daily basis.

WHITE PLAINS, N.Y. Recent tests performed by ConsumerLab.com of Ginkgo biloba supplements found that few products meet quality standards. Among the products selected for review, two appeared to contain adulterated material and two others contained less ginkgo than claimed on their labels.

A fifth product failed to identify the part of the ginkgo plant used, a Food and Drug Administration labeling requirement.

Only three ginkgo supplements passed ConsumerLab.com’s tests, the company reported Tuesday.

The results were reported today in ConsumerLab.com’s Product Review of Supplements for Memory & Cognition Enhancement which focuses on three ingredients that have shown some promise in improving memory – Ginkgo biloba, huperzine A and acetyl-L-carnitine. Among the huperzine products selected, two passed testing while a third provided only 14 percent of its claimed amount of the ingredient. All five acetyl-L-carnitine supplements passed testing.

“Ginkgo extract is a moderately expensive ingredient. Some companies put less of it in their products than they claim or use ingredient that has been adulterated with inexpensive material that can fool non-specific tests,” charged William Obermeyer, ConsumerLab.com’s vice president for research. “Highly specific test methods, such as HPLC, reveal these shortcomings, allowing us to direct consumers toward products of better quality.”

RELATED NEWS

Coming toward the end of the calendar year, there will be many consumers perusing purchases of over-the-counter medicines and devices in an effort to deplete their flexible spending accounts, many of which still contain a “use-it-or-lose-it” provision.

Private label just keeps chugging along.
Thanks to strong consumer demand for lower-priced alternatives to national brands and retailer desires to differentiate themselves from the competition, private label seems to keep gaining more traction in the retail world.

In a Journal of Advanced Nursing study of 90 adults with type 2 diabetes published last week, female gender, elevated blood sugar levels, neuropathic pain, and fatigue were related to sleep disturbance, even after controlling for factors such as age, diabetes duration, depressive symptoms and distress.

Ascensia Diabetes Care, based out of Basel, Switzerland, is showing its support for World Diabetes Day 2017 by publishing 30 portraits of inspiring women who are making significant contributions to advancing diabetes care.

Forgotten Password

Registration complete

REGISTER

USERNAME *

Spaces are allowed; punctuation is not allowed except for periods, hyphens, and underscores.

E-MAIL ADDRESS *

A valid e-mail address. All e-mails from the system will be sent to this address. The e-mail address is not made public and will only be used if you wish to receive a new password or wish to receive certain news or notifications by e-mail.

Password *

Confirm Password *

Please choose a password for your account; it must be 8 - 30 characters. .

First Name *

Last Name *

Company Name *

Job Title *

ZIP *

Are you a *

Retailer or Healthcare professional

Non-Retailer

How many stores do you operate?: *

Which best describes the business/industry you work in?: *

Which best describes your job title?: *

Please select the newsletters you would like to subscribe to

DSN A.M.
Daily news stories covering the retail drug industry

Breaking News
First-to-the-market with developing stories in the industry